Member Info for Doc83

*IF* Synairgen seen this through to the end themselves, i.e. don’t sell out or get TO, then IMO this is still boom or bust, £0 or £10+. Why? I don’t think there’s any halfway house here. I suppose the halfway house would be a TO, but if they decide they are going to the bitter end themselves it’ll either be a fail and the end of Synairgen or they’ll have got this drug approved and it’ll be worth potentially billions.

So the supposedly wild price estimates are perhaps not as wild as some make out. But as mentioned before, clearly it’s a long, risky and difficult road ahead and the odds are against us. But the rewards are commensurate with said risk. That’s what some of the more negative posters fail to understand… if you want to invest in a stock that could see you retire decades ahead of schedule, accept that it could also blow up in your face.

MrCosts: “Not here to be popular, here to give my views.”

I think we all know your views, given that you say the same things on almost every post.

Fellow LSE members, like if you agree and maybe MrCosts will then realise he doesn’t need to remind us on a daily basis of his views!

Andybe4 - “It’s pathetic, the company is a university spin off…”

And yet like most of us you also invested pre February.

Kevin - they can’t be bad as they had passed us through to phase 3.

The mood has gone very dark on here. Darkest before dawn and all that?

Manifesto - fully aware Activ have the results but just haven’t released them for whatever reason.

I’m very wary on the dosing at winter comment. RM was clearly very confident we’d pass sprinter, hence the recruitment drive and all the other stuff.
I’m confident long term, but worry in the short term with these days, weeks and months rattling by.

Delivery of Activ p2 results continues to baffle me. The “summer” timescale given was a guess and Synairgen even said at the AGM that it was “out of their control”. As a betting man, I’d say it was now unlikely we’ll see it by the end of summer (next week Friday!). But we know we’ll get it eventually. No help right now, though.

Market is seeing September already flying by with no news. Expect to see it deteriorate further if nothing by month end.
Does this matter for a LTH who believes this will end positively, even if it takes years? No.
But I’m under no illusions that if we don’t get on a new trial soon, then the SP could well go to the level a lot of the derampers have been quoting.

Very sad news yesterday. Whether you're a fan of the royals or not, no one can argue what a servant the Queen was for this country. Some of our politicians could learn a thing or two from her.

I can’t me selling out, or certainly not all of my shares, until the end.
Why? I think Docdaneeka has said something similar but lots on here say if the SP gets back to £1 that they’ll be breakeven and will sell. But if the SP does jump to £1 then something materially very good will have happened. I don’t think I could risk selling for example at £1 and then see Synairgen get bought out for £5. I’d never forgive myself and I’d find that more painful than if this goes to £0.

Genki - maybe. But the reality is that only large pharma is likely to buy us out. And when you consider the 10’s of $billions they make, even a 10% swing in the currency is not going to make much of a difference to them. Ultimately, if they want to buy then the currency will not be a factor at all IMO.

Axe: "Me I am in the realist Investment corner..."

Then surely you knew the risks here and that what happened in February was not unusual for a drug discovery/development company? Every company like this you'll see its SP go up and down like a wh0re's drawers. They are long shots, educated gambles and the rewards are therefore potentially big.

We'll see if the presentation today is just regurgitating "old news". Seems strange to release an RNS if it is.

What lovely news to wake up to. Good job I read the RNS before coming here, because reading comments from some of the usual suspects you’d think it was bad news!

COPD is the third biggest killer and the opportunities here have always been potentially massive. Large pharma and those who know (not Burstead and co!) will know this and it will surely put us in a slightly more prominent shop window, be it for a PT or even a TO.

A long, long way still to go. But as I said earlier in the week we have to let bygones be bygones and let the BOD get on with things, which they clearly are.

And Tommy is right… easy to spot the genuine holders here today. MrCosts - while it might not be a £10 per share TO or PT, you cannot possible say this is not good news. Axe - I don’t know what has happened to you, you used to be a great, balanced contributor. Have one final go at clearing your chest and let’s get back to seeing if we can all salvage something from February.

I’ve been rather busy the last few weeks and especially so this week renovating my house but great to get home after along day and see what looks positive news for Synairgen.

We’re due a positive ‘surprise’ for a change!

Kevin, we know we are due ACTIV-2 P2 data, which presumably given we passed it must be at least half decent. And there is still reasonable hope we can get onto another trial(s). We can't say the company has failed and is dead duck just yet.

But I do agree we shouldn't ramp it, but instead be realistic. It's a long shot. But it could still come off.

A lot of frustration on here (again), but sadly, as we've discussed ad nauseum, things are now out of Synairgen's control...

ACTIV-2 P2 data? We're waiting on the NIH. Not Synairgen's fault.
New trial(s), perhaps strive? We're waiting on someone else.

As critical as I've been on the lack of communication, I think we have to cut them some slack here.

I can’t believe some on here thought Mr Costs and Tommy were being serious!

And Aether, you’re effectively asking how long is a piece of string! All we know is that IF we get on another trial and ACTIV P2 data is very good, the SP will go up… IMO to around 50-80p.
And if we pass a P3 trial, then the sky is the limit.

But there’s lots of big hurdles to get over. And there’s huge risk and a real chance this could all go belly up. Hence why the rewards would be so big.

Risk versus reward. Many on here don’t seem to understand that.

I can’t see how Polygon could sell their stake now. As Ghia says, landing 60 million shares or whatever it is now into the market would decimate the SP. In fact, unless they had a buyer already lined up l, they just wouldn’t be able to sell them.

My bet is that they are ultimately looking for a TO, especially post February’s bad news. I suppose one could have argued that pre February, if Synairgen had become the next Moderna, they could have held on years until the company became fully matured and paying dividends. But I doubt it. I think they’ve always looked at this as ultimately being bought out.

If we do get onto another P3 trial and many other stars align to the point a large pharma co comes bidding £5 per share, it would be interesting to see if they put pressure on the BOD to accept it, or wait for the results and gamble it going much higher, of course running the risk of another sprinter p3 debacle.

Mani - you are living proof that you’ll never win an argument with a woman! I gave up trying a long time ago with my own wife.

Mani: The Board want success as much as we do.... It is a life's work for some
of our Scientists..... They lost millions on Feb 21st...... You can be sure
they want to get it back and some...... How else will they afford to pay their energy
bills in retirement....:))

Mani, have you not see the considerable salaries and pension packages!? I think they’ll be fine in retirement, SNG success or not.

Aether, tweeting is communication… you know that is not a strong point for Synairgen!